Survival and Prognostic Factors in Patients with Solid Pseudopapillary Neoplasms of the Pancreas

Brandon M. Huffman, Gustavo Westin, Samer Alsidawi, Steven Robert Alberts, David M. Nagorney, Thorvardur R Halfdanarson, Amit Mahipal

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Prognostic factors for solid pseudopapillary neoplasms (SPN) of the pancreas have been incompletely defined in the literature. We aimed to use the National Cancer Database to describe survival and characterize prognostic factors in patients with pancreatic pseudopapillary neoplasms. Methods We identified 304 patients with pancreatic SPN diagnosed between 2004 and 2012 using the National Cancer Database. All patients were included in the survival analysis. Kaplan-Meier method, χ2, and log-rank tests were used for statistical analysis. Cox proportional hazard regression model was used for multivariate analysis. Results The median age at diagnosis was 36.5 years. Eighty-five percent of patients were female, 69% were white, and 25% were black. Metastases were observed in 5% of patients. Median tumor size was 5.1 cm. Ninety-two percent of patients underwent primary tumor resection. At 60 months, 98% of patients who underwent resection were alive, and 40% who did not undergo resection were alive. On multivariate analysis, female sex, resection of primary tumor, and absence of metastasis were correlated with improved survival. Conclusions Patients with SPN who undergo resection have an excellent survival at 5 years. Surgery should be considered in all patients with this diagnosis.

Original languageEnglish (US)
Pages (from-to)1003-1007
Number of pages5
JournalPancreas
Volume47
Issue number8
DOIs
StatePublished - Sep 1 2018

Fingerprint

Pancreatic Neoplasms
Survival
Neoplasms
Multivariate Analysis
Databases
Neoplasm Metastasis
Survival Analysis
Proportional Hazards Models

Keywords

  • Frantz tumor
  • National Cancer Database
  • pancreatic neoplasms
  • survival

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Survival and Prognostic Factors in Patients with Solid Pseudopapillary Neoplasms of the Pancreas. / Huffman, Brandon M.; Westin, Gustavo; Alsidawi, Samer; Alberts, Steven Robert; Nagorney, David M.; Halfdanarson, Thorvardur R; Mahipal, Amit.

In: Pancreas, Vol. 47, No. 8, 01.09.2018, p. 1003-1007.

Research output: Contribution to journalArticle

Huffman, Brandon M. ; Westin, Gustavo ; Alsidawi, Samer ; Alberts, Steven Robert ; Nagorney, David M. ; Halfdanarson, Thorvardur R ; Mahipal, Amit. / Survival and Prognostic Factors in Patients with Solid Pseudopapillary Neoplasms of the Pancreas. In: Pancreas. 2018 ; Vol. 47, No. 8. pp. 1003-1007.
@article{90fd2ef5558246a5a2036311e77202e5,
title = "Survival and Prognostic Factors in Patients with Solid Pseudopapillary Neoplasms of the Pancreas",
abstract = "Prognostic factors for solid pseudopapillary neoplasms (SPN) of the pancreas have been incompletely defined in the literature. We aimed to use the National Cancer Database to describe survival and characterize prognostic factors in patients with pancreatic pseudopapillary neoplasms. Methods We identified 304 patients with pancreatic SPN diagnosed between 2004 and 2012 using the National Cancer Database. All patients were included in the survival analysis. Kaplan-Meier method, χ2, and log-rank tests were used for statistical analysis. Cox proportional hazard regression model was used for multivariate analysis. Results The median age at diagnosis was 36.5 years. Eighty-five percent of patients were female, 69{\%} were white, and 25{\%} were black. Metastases were observed in 5{\%} of patients. Median tumor size was 5.1 cm. Ninety-two percent of patients underwent primary tumor resection. At 60 months, 98{\%} of patients who underwent resection were alive, and 40{\%} who did not undergo resection were alive. On multivariate analysis, female sex, resection of primary tumor, and absence of metastasis were correlated with improved survival. Conclusions Patients with SPN who undergo resection have an excellent survival at 5 years. Surgery should be considered in all patients with this diagnosis.",
keywords = "Frantz tumor, National Cancer Database, pancreatic neoplasms, survival",
author = "Huffman, {Brandon M.} and Gustavo Westin and Samer Alsidawi and Alberts, {Steven Robert} and Nagorney, {David M.} and Halfdanarson, {Thorvardur R} and Amit Mahipal",
year = "2018",
month = "9",
day = "1",
doi = "10.1097/MPA.0000000000001112",
language = "English (US)",
volume = "47",
pages = "1003--1007",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Survival and Prognostic Factors in Patients with Solid Pseudopapillary Neoplasms of the Pancreas

AU - Huffman, Brandon M.

AU - Westin, Gustavo

AU - Alsidawi, Samer

AU - Alberts, Steven Robert

AU - Nagorney, David M.

AU - Halfdanarson, Thorvardur R

AU - Mahipal, Amit

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Prognostic factors for solid pseudopapillary neoplasms (SPN) of the pancreas have been incompletely defined in the literature. We aimed to use the National Cancer Database to describe survival and characterize prognostic factors in patients with pancreatic pseudopapillary neoplasms. Methods We identified 304 patients with pancreatic SPN diagnosed between 2004 and 2012 using the National Cancer Database. All patients were included in the survival analysis. Kaplan-Meier method, χ2, and log-rank tests were used for statistical analysis. Cox proportional hazard regression model was used for multivariate analysis. Results The median age at diagnosis was 36.5 years. Eighty-five percent of patients were female, 69% were white, and 25% were black. Metastases were observed in 5% of patients. Median tumor size was 5.1 cm. Ninety-two percent of patients underwent primary tumor resection. At 60 months, 98% of patients who underwent resection were alive, and 40% who did not undergo resection were alive. On multivariate analysis, female sex, resection of primary tumor, and absence of metastasis were correlated with improved survival. Conclusions Patients with SPN who undergo resection have an excellent survival at 5 years. Surgery should be considered in all patients with this diagnosis.

AB - Prognostic factors for solid pseudopapillary neoplasms (SPN) of the pancreas have been incompletely defined in the literature. We aimed to use the National Cancer Database to describe survival and characterize prognostic factors in patients with pancreatic pseudopapillary neoplasms. Methods We identified 304 patients with pancreatic SPN diagnosed between 2004 and 2012 using the National Cancer Database. All patients were included in the survival analysis. Kaplan-Meier method, χ2, and log-rank tests were used for statistical analysis. Cox proportional hazard regression model was used for multivariate analysis. Results The median age at diagnosis was 36.5 years. Eighty-five percent of patients were female, 69% were white, and 25% were black. Metastases were observed in 5% of patients. Median tumor size was 5.1 cm. Ninety-two percent of patients underwent primary tumor resection. At 60 months, 98% of patients who underwent resection were alive, and 40% who did not undergo resection were alive. On multivariate analysis, female sex, resection of primary tumor, and absence of metastasis were correlated with improved survival. Conclusions Patients with SPN who undergo resection have an excellent survival at 5 years. Surgery should be considered in all patients with this diagnosis.

KW - Frantz tumor

KW - National Cancer Database

KW - pancreatic neoplasms

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=85051928670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051928670&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000001112

DO - 10.1097/MPA.0000000000001112

M3 - Article

C2 - 30036214

AN - SCOPUS:85051928670

VL - 47

SP - 1003

EP - 1007

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 8

ER -